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Abstract
Objectives: Post-traumatic stress symptoms (PTSS) have been identiﬁed as a meaningful indicator of
distress in cancer survivors. Distinct from young adult survivors of childhood cancer, young people
diagnosed with cancer as adolescents and young adults (AYAs) face unique psychosocial issues;
however, there is little published research of PTSS in the AYA population. This study examines
prevalence and predictors of PTSS among AYAs with cancer.
Methods: As part of a longitudinal study of AYAs with cancer, 151 patients aged 15–39 years
completed mailed surveys at 6 and 12 months post-diagnosis. Severity of PTSS was estimated at 6 and
12 months post-diagnosis. Multiple regression analyses were conducted to investigate the predictive
effects of socio-demographic and clinical characteristics on changes in PTSS over time.
Results: At 6 and 12 months, respectively, 39% and 44% of participants reported moderate to
severe levels of PTSS; 29% had PTSS levels suggestive of post-traumatic stress disorder. No signiﬁcant
differences in severity of PTSS between 6 and 12 months were observed. Regression analyses suggested
that a greater number of side effects were associated with higher levels of PTSS at 6 months. Currently
receiving treatment, having surgical treatment, diagnosis of a cancer type with a 90–100% survival rate,
remaining unemployed/not in school, and greater PTSS at 6 months were associated with higher levels of
PTSS at 12 months.
Conclusions: Post-traumatic stress symptoms were observed as early as 6 months following diagnosis
and remained stable at 12-month follow-up. The development of early interventions for reducing distress
among AYA patients in treatment is recommended.
Copyright © 2012 John Wiley & Sons, Ltd.
Introduction
Diagnosis and treatment of cancer constitute stressful and
life-threatening events. A growing body of literature has
examined traumatic qualities of cancer that relate to post-
traumatic stress symptoms (PTSS) and post-traumatic stress
disorder (PTSD) [1–3]. The experience of cancer includes
multiple and chronic stressors related to threatening life
and bodily integrity, such as diagnosis, severity of cancer,
invasive procedures, treatment side effects, risk of relapse,
and interference with physical and social functioning
[4,5]. For cancer patients, these stressors may emerge
repeatedly for an extended period. Because of these unique
characteristics of cancer as both acute (e.g. diagnosis)
and chronic (e.g. treatment) stressors, symptoms of post-
traumatic stress may emerge differentially over the course
of cancer.
Post-traumatic stress symptoms include re-experiencing
of the traumatic event, such as intrusive memories and
nightmares; avoidance of thoughts, feelings, and reminders
related to the trauma and emotional numbing; and persistent
arousal, such as hyper-vigilance and insomnia [6]. In
addition to exposure to a traumatic event, a diagnosis of
PTSD requires the presence of the above-described PTSS
symptoms, along with two additional criteria: PTSS persist
for at least 1 month after trauma; and PTSS symptoms
manifest physical symptoms and signiﬁcant impairment to
individuals’ functioning [6]. When patients suffer from
these symptoms, they may have difﬁculties in attending to
appointments or understanding information related to
medical care during visits [7]. This study focuses on the
prevalence and predictors of PTSS over 1 year among
adolescents and young adults (AYAs) recently diagnosedwith
cancer, an understudied population who may be receiving
inadequate psychosocial care.
Adolescents and young adults who are diagnosed with
cancer during their teenage or young adult years are at risk
for distress because they face unique challenges resulting
from coping with both their current developmental stage
and a life-threatening illness [8–11]. For example, AYAs
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with cancer experience disruptions in psychological and
social maturation, diminished autonomy in relationships
with their parents, stiﬂed educational attainment and
employment, and concerns related to sexuality and fertility,
social isolation, and physical changes resulting from
treatment [8–10,12–14]. Indeed, patients diagnosed with
cancer in adolescence and young adulthood experience
greater distress when compared with younger patients or
older adult patients with cancer [15–18]. Research on
PTSD and PTSS in the general population suggests that
adolescents are particularly vulnerable to PTSD because
the experience of trauma disrupts the ability to achieve
key development tasks such as developing a sense of
identity [19].
Despite the potential for great distress and PTSS in
AYAs, few studies have examined the prevalence and
predictors of PTSS in AYAs. Most studies of cancer-
related PTSS for this age group have focused on adolescent
and young adult survivors of childhood cancer. A series
of studies of adolescent and young adult survivors of
childhood cancer indicate that 3–21% of respondents
report clinically signiﬁcant levels of PTSS [1,20–33].
Considering that these studies are based on long-term
survivors of childhood cancer who are between 1 and
34 years post-diagnosis, the severity of PTSS may be
higher if closer to the time of diagnosis or treatment.
Studies suggest that PTSS are likely to be higher for those
who are receiving active treatment when compared with
those who are not [34,35]. For example, Phipps et al.
[35] observed differences in reporting PTSS over time,
with higher levels of PTSS observed in respondents who
were within 2 years of diagnosis compared with those
who were 2 to 5 years after completion of treatment. These
studies suggest that patients in treatment or early phases of
survivorship may experience more severe PTSS than long-
term survivors. Thus, it is crucial to understand to what
extent AYA patients with cancer experience PTSS in early
phases of survivorship in order to intervene early to reduce
the risk of PTSS and subsequent maladaptive outcomes
over time.
Risk factors for PTSS in childhood cancer survivors
include older age at diagnosis, female gender, unemploy-
ment, lower levels of educational attainment, and severe late
effects or health problems [1,27,29,31,36]. In addition,
studies of AYAs with cancer have observed greater
psychological distress in those who were female, older,
non-White, off treatment, and those who reported pain,
treatment-related side effects, and lower levels of physical
functioning [37–40].
The present study aims (i) to identify the prevalence of
PTSS at 6 and 12 months post-diagnosis and the risk of
PTSD at 12 months; (ii) to assess whether the prevalence
of PTSS changes over the ﬁrst year of diagnosis; and (iii)
to examine which demographic and health status variables
relate to changes in PTSS.
Method
Design, procedure, and participants
As part of a longitudinal study to observe changes in
psychological adaptation, quality of life, and health service
utilization over 2 years in AYA patients who were recently
diagnosed with cancer, the present study used data collected
within the ﬁrst year of the survey. Baseline data were
collected within the ﬁrst 4 months of diagnosis and,
subsequently, at 6 and 12 months after the baseline survey.
Participants were recruited from ﬁve tertiary care academic
medical centers (three children’s hospitals and two
university-afﬁliated adult care medical institutions) in
Los Angeles (California), Portland (Oregon), and San
Antonio (Texas) between March 2008 and April 2010.
Inclusion criteria were (i) diagnosis between the ages of
14 and 39 years (but anticipated to turn 15 years while in
treatment), (ii) ﬁrst diagnosis of and treatment for cancer,
and (iii) ability to read and understand English or Spanish.
Institutional review board approval from each partici-
pating site and the coordinating center was obtained.
Research staff in clinics identiﬁed 286 eligible patients
and sought physician approval for recruitment. Fifty-eight
patients were dropped because either physicians denied
access to patients who in their estimation were too sick
to participate or patients refused to participate. Of 228
AYAs recruited and consented to study, 12 did not return
a completed survey after providing consent, and one died.
Thus, the overall participation rate was 75% (n= 215).
Subjects received $25 incentive for completing the
questionnaire at each time point. Patient assent and parent
permission were obtained for those under age 18 years.
Measure
Dependent outcome
Post-traumatic stress symptoms: Post-traumatic stress
symptoms were assessed using the Posttraumatic Stress
Diagnostic Scale (PDS) [41] at 6-month follow-up
(Cronbach’s a 0.91) and again at 12-month follow-up
(Cronbach’s a 0.92). This measure includes 17 questions
covering three categories of symptoms: re-experiencing
(ﬁve items), avoidance (seven items), and arousal (ﬁve
items). We adapted the items in the PDS by replacing
the word ‘trauma’ with ‘cancer’ in order to speciﬁcally
investigate cancer-related PTSS. Each symptom was rated
on a scale of 0–3 for frequency in the past month (0 = not
at all or only one time, 1 = once in a while, 2 = one-half of
the time, and 3 = almost always). Item scores are summed
to derive an overall severity score ranging from 0 to 51.
On the basis of prior administrations of this instrument,
a score less than 10 indicates mild symptom severity,
11–20 indicates moderate, 21–35 signiﬁes moderate to
severe, and 36 and above indicates severe symptoms
[25,41,42]. Severity scores for re-experiencing, avoidance,
and arousal also were calculated by summing subscale
items.
Risk for post-traumatic stress disorder: On the basis of
prior studies of PTSS in childhood cancer survivors
[28,43], DSM-IV diagnostic criteria for PTSD can be used
for determining PTSS scores that may suggest risk of
PTSD (yes/no). Risk of PTSD in this study was estimated
by determining whether respondents met DSM-IV criteria
A through F. All patients satisﬁed criterion A and E
because their diagnosis and treatment constituted a
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traumatic event (criterion A), and the surveys for PTSS
were conducted more than 1 month after initial cancer
diagnosis (criterion E, presence of symptoms for
>1 month after the event). The PDS was used to assess
PTSD criteria B, C, and D. Symptoms rated ≥1 (once in
a while) were counted as present for each PTSS symptom.
To satisfy criterion B, the presence of at least one
symptom related to re-experiencing was required. For
criterion C, the presence of at least three symptoms related
to avoidance was required. Patients who endorsed presence
of two symptoms related to arousal were considered to
meet criterion D. Last, the Brief Symptoms Inventory-18
(BSI-18) [44] and the Medical Outcomes Study 36-Item
Short Form Health Survey (SF-36) [45] were used to
examine PTSD criterion F—the existence of signiﬁcant
distress and functional impairment, respectively. The
BSI-18 consists of 18 items, yielding a global distress index
(GSI) and three subscales of depression, anxiety, and
somatization. Respondents indicated how much they had
been bothered by each symptom over the previous 7 days,
using a 5-point scale, ranging from 0 (‘not at all’) to 4
(‘extremely’). Raw scores were converted to age-adjusted
and gender-adjusted T-scores on the basis of adult non-
patient community norms. A GSI score of ≥63 or a score
of≥63 on any two of the three subscales signiﬁes clinically
signiﬁcant distress (criterion F). BSI was administered at
6-month (Cronbach’s a 0.90) and 12-month (Cronbach’s a
0.93) follow-up. To assess impairment in functioning
(PTSD criteria F), the SF-36 subscale assessing role
limitations due to emotional health was used. A transformed
T-score less than or equal to 40 indicates functional
impairment. Respondents completed the SF-36 at baseline
and at 12-month follow-up (Cronbach’s a 0.91); therefore,
statistical models examining a risk of PTSD using DSM-IV
criteria were derived for 12-month follow-up only.
Socio-demographic characteristics
Self-reported socio-demographic variables were collected
at baseline and included gender, race, employment/school
status, and marital/relationship status. Age at diagnosis
was categorized into three age groupings (14–19, 20–29,
and 30–39 years) to estimate developmental life stages
within this broad age range, using theoretical models of
human development [46,47]. Patients reported their
employment/school status at both baseline and prior to
diagnosis, as well as at each subsequent time point of data
collection. Respondents were categorized as ‘employed/in
school’ when they were employed full-time/part time, full-
time homemaker, or full-time student. Those who were on
temporary medical leave/disability, unemployed, or
permanently unable to work were coded as ‘unemployed/
not in school’. To evaluate the impact of employment/
school status on outcomes, we categorized patients into four
groups: (i) employed/in school before diagnosis and at each
subsequent time point; (ii) employed/in school before
diagnosis but stopped at a subsequent time point without
returning; (iii) unemployed/not in school before diagnosis
and remained unemployed/not in school at each time point;
and (iv) unemployed/not in school before diagnosis but
initiated employment/school involvement at a subsequent
time point.
Clinical characteristics
Through medical chart review, information about clinical
characteristics obtained by the research staff included
types of cancer, types of treatment, treatment status
(on vs. off treatment), and types of surgery (e.g., treatment-
related surgery, including bone marrow transplant, tumor
resection, and central line placement; and non-treatment
related such as staging procedures). Severity of disease
was determined by using Surveillance Epidemiology and
End Results codes to distinguish ‘curable’ forms of cancer
from those with more uncertain prognosis [48]. Cluster 1
included diseases for which the 5-year survival rates are
90% or greater (Hodgkin’s lymphoma, testicular tumors,
and thyroid cancer) and account for 39% of all incident
cases of invasive cancers in AYAs aged 15–39 years in
the USA [49]. Cluster 2 was composed of all other invasive
malignancies (61% of remaining incident cases in the
USA) with expected 5-year survival rates of less than
90%. Via self-report, a symptom checklist, derived by the
investigators, elicited subject endorsement of 11 common
treatment-related side effects (6-month follow-up only)
(i.e. shortness of breath, memory or concentration problems,
stomach or chest pain, ringing in ears, pain in joints, weight
loss, frequent fevers, sleep difﬁculty, tiredness or fatigue,
mouth sores, and frequent headaches), which were summed
and considered in statistical analyses [48].
Analytic strategies
To identify the prevalence of PTSS over 1 year, we ﬁrst
examined descriptive statistics summarizing PTSS severity
scores at 6-month and 12-month follow-up. We estimated
the proportion of patients who were at risk of PTSD at
12-month follow-up. Changes in PTSS between 6-month
and 12-month follow-up were tested by using a paired T-test
and a Wilcoxon signed-rank test. A paired T-test was
conducted to compare means of PTSS scores at 6 months with
those at 12 months. A Wilcoxon signed-rank test was used to
examine if respondents’ categorical PTSS severity level had
changed between 6-month and 12-month follow-up.
Next, we investigated predictors of changes in PTSS
between 6-month and 12-month follow-up by using
univariate and multivariate analyses. Repeated-measures
ANOVAs were calculated for PTSS at 6-month and
12-month follow-up to examine whether change in
respondents’ PTSS scores were dependent upon socio-
demographic and clinical characteristics. Last, multivariate
linear regression was employed to investigate the predictive
effects of socio-demographic and clinical characteristics on
PTSS scores at 6-month and 12-month follow-up. On the
basis of the results of repeated-measures ANOVAs, a
p-value of <0.20 was used as a conservative criteria for
selecting independent variables to include in multivariable
models. Race and marital status were excluded in the
regression model because p-values of both variables were
greater than 0.20 in the univariate models. In the multivari-
ate regressionmodel, age at diagnosis, gender, employment/
school status, severity of disease, type of surgery, treatment
status, and side effects were included as covariates. Type
of treatment was excluded from analyses because virtually
all respondents had received either chemotherapy or radia-
tion. In regression analyses, 19 cases were dropped
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because of missing data in the measure of surgical types
(n= 13), employment/school status (n= 6), and side effects
(n= 2). A square-root transformation of PTSS scores was
used in the analyses because the distribution for PTSS in
this sample was highly negatively skewed. Summary
scores of PTSS presented in tables were back transformed
for interpretation. STATA v.11.2 (StataCorp. 2009. Stata
Statistical Software: Release 11. College Station, TX:
StataCorp LP) was used in analyzing the data.
Results
Baseline characteristics
Table 1 presents demographic and clinical characteristics
of participants at baseline. Characteristics are provided
for the overall group who participated at baseline
(n= 215) and the subgroup who completed surveys at both
6-month and 12-month follow-up (n= 151). Among the
64 participants who did not complete follow-up surveys,
14 had died, 17 passively refused, and 33 responded to only
one of the follow-up surveys. No signiﬁcant differences in
demographic and clinical characteristics were observed for
these 64 patients lost to attrition and the 151 who completed
data at all time points, except for age. Older patients were
more likely to drop out than younger patients.
The prevalence of PTSS and changes in PTSS over
1 year
Mean and distribution of PTSS severity scores are
summarized in Table 2. Mean PTSS scores are 11.09 at
6-month follow-up and 10.89 at 12-month follow-up
(t[150] = 0.90, p= 0.36). Subscales of re-experiencing and
avoidance show slight decreases between 6-month
follow-up and 12-month follow-up (t[145] = 1.78, p=0.08;
t[149] = 1.09, p=0.28, respectively), whereas arousal
increases slightly (t[145] =1.05, p=0.30). Median scores
in PTSS were 9 for both 6-month and 12-month follow-up.
About one-fourth of AYAs reported moderate levels of
PTSS, 10% reported moderate to severe levels of PTSS,
and 3% reported severe levels of PTSS at 6-month
follow-up. At 12-month follow-up, small but statistically
non-signiﬁcant increases in the proportion of moderate
and moderate to severe levels of PTSS were observed
(p= 0.15 in signed-rank test). Twenty-nine percent of
respondents’ scores on the PDS, SF-36, andBSI-18 suggested
risk of PTSD.
The predictors of changes in PTSS over 1 year
Univariate analyses
Table 3 presents results from repeated-measures ANOVAs.
Only change in employment/school status after diagnosis
appeared associated with changes in PTSS scores between
6-month and 12-month follow-up. Individuals who were
unemployed/not in school before diagnosis reported
increases in PTSS between 6-month and 12-month
follow-up regardless of their current employment/school
status. Those who were employed or in school before
diagnosis but stopped their work or school reported almost
no changes in PTSS scores. However, individuals who
remain employed/in school after diagnosis reported slight
decreases in PTSS scores. Finally, side effects measured
at 6-month follow-up were signiﬁcantly associated with
levels of PTSS at 6-month follow-up (Pearson’s correla-
tion coefﬁcient 0.43, p< 0.001) and levels of PTSS at
12-month follow-up (Pearson’s correlation coefﬁcient
0.35, p< 0.001).
Table 1. Socio-demographic and clinical characteristics of
participants
Baseline
(N=215)
Completed at 6 and
12 months (N=151)
Socio-demographic characteristics
Age (baseline) 23.7 (8.8) 22.9 (9.0)
Gender (baseline)
Female 101 (47.0%) 68 (45.0%)
Male 114 (53.0%) 83 (55.0%)
Race (baseline)
White/Caucasian 95 (44.6%) 67 (45.0%)
Hispanic/Latino 91 (42.7%) 68 (45.6%)
Others 27 (12.7%) 14 (9.4%)
Education (baseline)
Less than high school 102 (47.9%) 78 (52.4%)
High school graduate 31 (14.6%) 18 (12.1%)
Some college 45 (21.1%) 32 (21.4%)
College graduate and above 35 (16.4%) 21 (14.1%)
Marital status (baseline)
Married/partnered 81 (39.4%) 50 (33.8%)
Not married 130 (61.6%) 98 (66.2%)
Employment/school status after diagnosis (12 months)
Remained employed/in school 88 (55.4%) 81 (55.5%)
Stopped employment/school 44 (27.7%) 40 (27.4%)
Remained unemployed/not in school 12 (7.6%) 12 (8.2%)
Started employment/school 15 (9.4%) 13 (8.9%)
Clinical characteristics
Age at diagnosis (baseline) 23.6 (8.9) 22.7 (9.0)
Age group at diagnosis (baseline)
14–19 years 111 (51.6%) 87 (57.6%)
20–29 years 39 (18.2%) 20 (13.3%)
30–39 years 65 (30.2%) 44 (29.1%)
Type of cancer (baseline)
Hodgkin’s disease 23 (10.8%) 16 (10.6%)
Non-Hodgkin’s lymphoma 17 (7.9%) 12 (8.0%)
Testicular cancer 14 (6.5%) 7 (4.6%)
Female reproductive cancers 8 (3.7%) 2 (1.3%)
Soft-tissue sarcoma 21 (9.8%) 18 (11.9%)
Brain 14 (6.5%) 12 (8.0%)
Leukemia 50 (23.4%) 41 (27.2%)
Other carcinomas 21 (9.9%) 11 (7.4%)
Breast 19 (8.9%) 13 (8.6%)
Bone tumors 26 (12.2%) 19 (12.6%)
Types of treatment (cumulative, 12 months)
Chemotherapy 183 (93.9%) 139 (92.1%)
Radiation 46 (27.4%) 33 (27.9%)
Surgery 117 (63.2%) 84 (55.6%)
Bone marrow transplants 15 (7.0%) 13 (8.6%)
Type of surgery (cumulative, 12 months)
No surgery (chemotherapy or
radiation only)
60 (35.3%) 60 (42.9%)
Treatment-related surgery (including
bone marrow transplants, catheter
placement)
92 (54.1%) 67 (47.9%)
Staging-related surgery 18 (10.6%) 13 (9.3%)
Treatment status (at 12 months)
Stop treatment 77 (46.7%) 67 (44.4%)
On active treatment 88 (53.3%) 84 (55.6%)
Number of side effects (0~11)
(at 6 months)
3.53 (2.47) 3.50 (2.49)
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Multivariate analyses
Table 4 summarizes results frommultivariate linear regression
analyses inclusive of age at diagnosis, gender, employment/
school status, severity of cancer, type of surgery, and current
treatment status as covariates. At 6-month follow-up, severity
of PTSS was associated with side effects. Those who had
greater number of side effects reported higher levels of PTSS.
In addition, the association of cancer severity and PTSS was
marginally signiﬁcant: Patients with higher survival rate
cancers reported higher levels of PTSS than did those with
lower survival rate cancers. Socio-demographic factors
and clinical characteristics explained 20.9% of variance
in PTSS at 6-month follow-up.
At 12-month follow-up, 56.6% of variance for PTSS
was explained solely by PTSS at 6 months (Table 4).
PTSS were signiﬁcantly greater for patients with cancers
of higher survival rates. Patients who received staging-
related surgery reported signiﬁcantly lower levels of PTSS
than those who received treatment-related surgery. PTSS
were signiﬁcantly greater for patients who were on active
treatment. Among socio-demographic variables, employment/
school status appeared as a signiﬁcant predictor of PTSS
at 12-month follow-up. Compared with AYAs who
remained employed/in school throughout their diagnosis
and treatment, patients who were not at all employed/in
school reported signiﬁcantly higher levels of PTSS.
Disruption in employment/school work after diagnosis also
was associated with higher levels of PTSS at 12-month
follow-up, but at a marginally signiﬁcant level.
Discussion
This study examined the prevalence and predictors of
PTSS as well as changes in PTSS over the course of 1 year.
The results showed that 44% of AYA patients reported at
least moderate levels of PTSS approximately 1 year
following their cancer diagnoses and 3% experienced
severe levels of PTSS. When the full criteria of DSM-IV
were used to estimate the risk of PTSD at a 12-month
follow-up, 29% of AYAs reported risk of PTSD. The
proportion of patients at risk of PTSD at 12 months
post-diagnosis in this study is higher than that reported
by Stuber et al. [28], who used the same method for
estimated risk of PTSD as reported here. In their study
of long-term survivors of childhood cancer, Stuber and
Table 2. Means and distributions of PTSS (N= 151)
N
6-month
follow-up
12-month
follow-up
Severity scores
PTSS severity (0–51) 151 11.09 (9.87)a 10.89 (9.80)
Re-experiencing (0–15) 146 3.16 (3.45) 2.93 (3.40)
Avoidance (0–21) 150 4.33 (4.20) 4.23 (4.48)
Arousal (0–15) 146 3.70 (3.67) 3.77 (3.36)
Ordinal rating of severity
Mild (0–10) 92 (60.9%)b 84 (55.6%)
Moderate (11–20) 38 (25.2%) 42 (27.8%)
Moderate to severe (21–35) 16 (10.6%) 21 (13.9%)
Severe (3–51) 5 (3.3%) 4 (2.7%)
Risk of PTSD based on the full DSM-IV criteria
At risk of PTSD — 44 (29.1%)
Not at risk of PTSD — 107 (70.9%)
aNumbers in parentheses are standard deviations.
bNumbers presented ﬁrst are frequencies, and numbers in the parentheses are
percentages.
Table 3. Changes in transformed PTSS over time by subgroups
Mean (S.D.)a Group Time GroupTimeb
6-month follow-up 12-month follow-up p p p
Age at diagnosis (categorical) (n=151)
14–19 years (n=87) 8.88 (2.46) 8.21 (2.54) 0.766 0.823 0.071
20–29 years (n=20) 6.46 (1.31) 8.75 (2.47)
30–39 years (n=44) 9.94 (2.30) 8.52 (2.65)
Gender (n=151)
Female (n=68) 10.24 (2.29) 8.81 (2.74) 0.247 0.291 0.114
Male (n=83) 7.76 (2.20) 8.02 (2.39)
Race (n=149)
White (n=67) 8.46 (1.81) 8.20 (1.99) 0.382 0.757 0.710
Non-White (n=82) 9.10 (2.70) 8.44 (3.06)
Marital status (baseline) (n=148)
Not married/partnered (n=98) 8.63 (2.34) 8.12 (2.51) 0.707 0.366 0.985
Married/partnered (n=50) 9.19 (2.28) 8.69 (2.70)
Changes in employment/school status after diagnosis (before diagnosis vs. 12-month) (n=146)
Remained employed/school (n=81) 8.79 (2.03) 7.11 (2.61) 0.560 0.175 <0.05
Stopped employment/school (n=40) 10.20 (2.79) 10.27 (2.54)
Remained unemployed/not in school (n=12) 6.42 (3.00) 10.18 (2.80)
Started employment/school (n=13) 6.74 (2.28) 8.21 (2.27)
Severity of disease (n=151)
Low survival rate (n=126) 8.74 (2.41) 7.93 (2.47) 0.381 0.687 0.110
High survival rate (n=25) 9.29 (1.61) 10.78 (2.77)
Types of surgery (cumulative, 12-month) (n=140)
Treatment-related surgery (n=67) 9.10 (2.88) 8.45 (2.59) 0.793 0.160 0.329
Staging-related surgery (n=13) 11.58 (1.70) 8.79 (1.40)
No surgery (chemotherapy or radiation) (n=60) 8.18 (1.83) 8.43 (2.80)
aMean and conﬁdence intervals are back-transformed PTSS scores.
bRepeated-measures ANOVAs were conducted on the basis of transformed scores for PTSS measures.
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colleagues estimated that 9% of childhood cancer survivors
and 2% of siblings indicated risk of PTSD; however,
the CCSS cohort is composed of survivors who were
15–34 years post-diagnosis. Other prior studies of long-term
survivors of childhood cancer that used various methods to
determine PTSD have reported rates of PTSD ranging from
3% to 21% [1,5,20–26]. A study that examined PTSS in 30
children with cancer at 5 to 6 weeks after diagnosis found
that 10% showed severe symptoms suggestive of PTSD
[50]. Studies of older adult cancer patients in treatment
found 2.4–22% of patients indicating risk of PTSD by
using a structured interview by clinicians or self-reported
measures of PTSS [51,52]. In the study reported here,
the mean PTSS scores for AYA patients at 6-month and
12-month follow-up were 11.09 and 10.89, respectively,
which are again higher than the mean PTSS scores of young
adult survivors reported in a previous study using the PDS
(M= 6.6, SD=8.1, n=820) [53]. Differences in assessment
methods, measures, sample sizes, years since diagnosis,
treatment status (being on or off treatment), and sample
characteristics across studies of young adult cancer survivors
make it difﬁcult to compare rates across studies and
determine a deﬁnitive prevalence rate for PTSS in this
population. Yet, the substantial portion of the sample in
this study that reported moderate levels of PTSS as well
as a potential risk of PTSD warrants further research and
clinical attention in the AYA population.
The high levels of PTSS among AYA patients may be
explained by a greater degree of vulnerability to traumatic
stress during stages of adolescence and young adulthood
[2,33,47,54,55]. When adolescents and young adult
patients with cancer deal with issues related to normative
developmental tasks and the need to cope with life-
threatening illnesses at the same time, these complex
situations contribute to greater difﬁculties in reference to
psychological adjustment [8–10,12–14]. Such difﬁculties
may exacerbate their perceptions and experiences of their
diagnoses of cancer and cancer-related treatments as
traumatic events. However, this interpretation of the
elevated PTSS in our data should be approached with
caution. PTSS in this study was measured at 6 and
12 months after baseline surveys; more than half of the
participants were still receiving some type of medical
treatment at the 12-month assessment. Some of the PTSS
symptoms may have been compounded by side effects,
anxiety, or distress related to cancer treatment [4]. High
rates of prevalence of PTSS may reﬂect normal reactions
and responses to stressful situations, rather than indicating
psychiatric conditions [7]. Furthermore, AYA patients
undergoing cancer treatment in this study may still have
been experiencing ongoing treatment as trauma at the time
of assessment. The possibility of re-traumatization during
treatment makes it unclear in terms of which event
constitutes a trauma and which events patients perceive as
traumatic [7,56]. Despite the lack of knowledge regarding
speciﬁc traumatic events for patients in treatment, PTSS
seems to appear among AYA patients during treatment
and might be related to health behaviors and quality of life
in the future. Future studies should be conducted to address
these limitations by assessing traumatic aspects of cancer
among those who had been recently diagnosed and in active
treatment, the impact of traumatic aspects of cancer and PTSS
that deal with developmental tasks for AYA patients with
cancer, and longitudinal changes in their traumatic responses.
Findings also indicated that PTSS manifested as early
as 6 months post-diagnosis and did not increase or
decrease signiﬁcantly thereafter. This ﬁnding is consistent
with work carried out by Phipps and colleagues [35] in
which similar levels of PTSS were observed in childhood
cancer survivors 6 to 18 months post-diagnosis. However,
these ﬁndings contrast with published longitudinal
research on older adult cancer patients and families of
cancer patients, in which PTSS decreased within a relatively
short period [51,57–60].
Table 4. Linear regression analyses to predict PTSS at 6-month and 12-month follow-up (n= 132)
Dependent variable
PTSS at 6 months PTSS at 12 months
b p b p
PTSS at 6-month follow-up 0.810 <0.001
Age at diagnosis (categorical)
14–19 years REF REF
20–29 years 0.382 0.322 0.314 0.272
30–39 years 0.112 0.687 0.053 0.795
Gender (1 =male) 0.330 0.191 0.135 0.456
Changes in employment/school status after diagnosis
Remained employed/school REF REF
Stopped employment/school 0.412 0.150 0.372 0.082
Remained unemployed/not in school 0.572 0.139 0.710 <0.05
Started employment/school 0.631 0.353 0.414 0.212
Severity of disease (1 = high survival rate) 0.764 0.067 1.07 <0.001
Types of surgery (cumulative)
Treatment-related surgery REF REF
Staging-related surgery 0.051 0.916 0.940 <0.05
No surgery (chemotherapy or radiation) 0.147 0.573 0.052 0.776
Treatment status (1 = on treatment) 0.085 0.762 0.499 <0.01
Side effects at 6-month follow-up 0.272 <0.001 0.019 0.642
(Intercept) 2.185 <0.001 0.122 0.671
R2 0.276 0.665
Adjusted R2 0.209 0.631
F 4.15 <0.001 19.69 <0.001
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Findings revealed that those whomaintained employment/
school attendance after diagnosis experienced signiﬁcantly
lower levels of PTSS at 12-month follow-up compared with
those who were not employed or in school before and after
diagnosis. This result suggests that being unemployed/not
in school before diagnosis may be amarker of other stressors,
such as ﬁnancial strain, which is associated with increases in
PTSS. This ﬁnding is also consistent with previous studies
indicating the correlations between unemployment and
distress [1,27,29,31,36]. In addition, those who stopped
work or school after diagnosis reported marginally
signiﬁcantly higher levels of PTSS at 12-month follow-up
than those who were employed/in school after diagnosis,
suggesting the importance of maintaining AYA’s
involvement in work or school to the extent possible.
Remaining occupied in school or work may provide
AYAs with a social support system and sense of control
over their lives that serve to buffer the traumatic aspects
of cancer and its treatment. Alternatively, maintaining
involvement in school or work may simply function as a
behavioral indicator of people who are not substantially
affected by cancer-induced PTSS and/or side effects in the
ﬁrst place.
In terms of clinical characteristics and their relationship
to PTSS, the ﬁnding that reporting side effects was
associated with PTSS is consistent with the previous
studies of long-term survivors of childhood cancer [29],
which found that survivors who hadworse health conditions
and lower levels of physical health-related quality of life
showed more PTSS than those who did not. As pain and
worsening health conditions resulting from cancer treatment
are often regarded by patients as the most frightening
aspects in the cancer process [61], it is possible that poor
physical symptoms and health conditions are experienced
as reoccurring traumas that elevate the risk of developing
PTSS. In addition, we note the counter-intuitive ﬁnding that
AYAs with high survival rate cancers indicated higher
levels of PTSS than did those with low survival rate cancers.
This ﬁnding conﬂicts with childhood cancer survivor
studies in which severity of illness was not observed to be
related to PTSS [62]. This ﬁnding may imply that severity
of disease is relevant only to the extent to which AYA
patients perceive cancer as traumatic. It may be that AYAs
with a high potential for survival still struggle in reconciling
fears about their future with oncologists assurances that they
will be ‘cured’ or that the type of cancer they have is ‘a good
kind of cancer’ relative to those with a worse prognosis. It
also is possible that patients with high survival rate cancers
have less contact with medical staff than other cancer
patients because of their shorter periods of treatment and
follow-up, and thus experience less support and encourage-
ment from their oncology care providers. This lack of
perceived support during the course of illness may lead to
an estimation of their perceiving cancer and its treatment
as more traumatic when compared with AYAs with low
survival-rate cancers. Future research is needed to examine
how changes in the perceptions of a diagnosis of cancer and
its treatment over time differ depending on the severity of
the cancer. Types of surgery that patients received were
signiﬁcantly related to PTSS at 12-month follow-up.
Patients who received surgical treatment reported greater
PTSS than those who received staging-related surgery. This
ﬁnding suggests that surgical treatment for cancer is more
physically invasive compared with staging-related surgeries
and therefore can be perceived as more traumatic for
patients. Last, treatment status appeared as a signiﬁcant
predictor for PTSS at 12-month follow-up. Treatment may
not only serve as a traumatic event for cancer patients but
also as a constant reminder of traumatic events related to
cancer experienced in the past. Thus, patients who were
on active treatment report greater PTSS.
The ﬁndings of this study illustrate the fact that a
relatively high rate of AYA patients with cancer experience
clinically signiﬁcant levels of PTSS in the ﬁrst year of
diagnosis and that the levels of PTSS stabilize from 6 to
12 months after diagnosis. These ﬁndings emphasize the
importance of early screening and intervention for PTSS
among AYA patients with cancer as early as the ﬁrst
6 months following diagnosis. As existing interventions
targeting PTSS among AYAs with cancer focus on long-
term survivors of childhood cancer or families of children
recently diagnosed with cancer [63–65], data from this
study suggest that preventive interventions to alleviate
PTSS should be developed for recently diagnosed AYAs.
The risk factors found in this study, such as employment/
school status before and after diagnosis, severity of disease,
type of surgery, current treatment status, and side effects,
can be used to identify and screen people who practice
high-risk activities among recently diagnosed AYA patients
and monitor over time.
This study’s strengths include its moderately sized and
ethnically diverse multi-institutional sample of AYAs
recruited for this prospective, longitudinal study relatively
close to the time of their initial cancer diagnoses, along
with a high participation rate (75%) and equal gender
distribution. A well-validated measure of PTSS was utilized
at two key time points across the survivorship continuum.
The study is somewhat limited by the study design, which
does not include a control group. The inclusion of a control
group would be helpful in terms of estimating in a more
accurate and rigorous way to what extent PTSS is elevated
by cancer or cancer-related factors. In addition, the measure
for risk of PTSD was limited because we did not assess
participants’ reactions to traumatic events (i.e., reactions
involving intense fear, helplessness, or horror), which refers
to the PTSD criteria A2 in DSM-IV. This study assumed
that all participants would satisfy this criterion, but this
may not have been true for some participants. Finally, the
study did not include data on the subjective appraisal of
traumatic events and trauma history before the diagnosis
of cancer. As previous research identiﬁed subjective
appraisals and prior histories of traumatic events as the
most inﬂuential predictive factors for PTSS and PTSD
[33,51,66,67], future studies should include investigations
of lifetime trauma history and the subjective appraisal of
traumatic events such as being diagnosed with cancer and
receiving medical treatment.
This study provides evidence of PTSS in AYA cancer
patients. It furthers our understanding of factors contributing
to increased risks of distress in the AYA population.
Future research should further develop clinical guidelines
that can help health-care professionals in pediatric or adult
settings to sensitively respond to the traumatic stress
experienced by AYA patients. In doing so, health care
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professionals may be able to assess distress and needs
related to traumatic stress in the early stages of cancer
treatment, and provide appropriate support to AYA
patients at risk of PTSD. Trauma-focused cognitive and
behavioral therapies are demonstrated as effective in
reducing distress [68,69]. Integrating them into peer
support models that are developmentally appropriate for
AYAs may prove fruitful in terms of reducing distress
and promoting quality of life. Future research that further
investigates the nature of PTSS and develops effective
care for ongoing PTSS among AYA patients would
improve the psychosocial adjustment of AYA patients
with cancer.
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